High Molecular Weight Proteins of Trypanosoma cruzi Reduce Cross-Reaction with Leishmania spp. in Serological Diagnosis Tests

Chagas disease is caused by the parasite Trypanosoma cruzi. Because of its distribution throughout Latin America, sometimes it can overlap with other parasitic diseases, such as leishmaniasis, caused by Leishmania spp. This might represent a problem when performing serological diagnosis, because both parasites share antigens, resulting in cross-reactions. In the present work we evaluated Mexican sera samples: 83.8% of chagasic patients recognized at least one antigen of high molecular weight (>95 kDa) when evaluated by Western blot. Proteins of 130 kDa and 160 kDa are predominantly being recognized by asymptomatic chagasic patients. When the proteins were extracted using Triton X-100 detergent, a larger number of specific T. cruzi proteins were obtained. This protein fraction can be used to increase specificity to 100% in Western blot assays without losing sensitivity of the test. High molecular weight proteins of T. cruzi include glycoproteins with a great amount of αMan (α-mannose), αGlc (α-glucose), GlcNAc (N-acetylglucosamine), and αGal (α-galactose) content and these structures play an essential role in antigens recognition by antibodies present in patients' sera.

[1]  H. García,et al.  Characterization of the carbohydrate components of Taenia solium oncosphere proteins and their role in the antigenicity , 2013, Parasitology Research.

[2]  Julie Clayton,et al.  Chagas disease 101 , 2010, Nature.

[3]  R. M. de Lederkremer,et al.  Glycobiology of Trypanosoma cruzi. , 2009, Advances in carbohydrate chemistry and biochemistry.

[4]  E. Umezawa,et al.  Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp , 2007, Clinical and Vaccine Immunology.

[5]  D. B. Weatherly,et al.  Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. , 2006, Journal of proteome research.

[6]  A. Frasch,et al.  Trypanosoma cruzi surface mucins: host-dependent coat diversity , 2006, Nature Reviews Microbiology.

[7]  J. F. da Silveira,et al.  Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American Countries , 2004, Journal of Clinical Microbiology.

[8]  A. Mills,et al.  Trypanosoma cruzi glycoprotein 72: Immunological analysis and cellular localization , 1992, Molecular and Cellular Biochemistry.

[9]  R. Teasdale,et al.  Secretory Pathway of Trypanosomatid Parasites , 2002, Microbiology and Molecular Biology Reviews.

[10]  V. Monteón,et al.  Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens. , 2001, Archives of medical research.

[11]  J. F. da Silveira,et al.  Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. , 2001, Trends in parasitology.

[12]  E. Umezawa,et al.  Alkaline soluble Trypanosoma cruzi epimastigote antigen (ASEA) applied to Dot-ELISA. , 1994, Revista do Instituto de Medicina Tropical de Sao Paulo.

[13]  F. Araújo Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids , 1986, Infection and immunity.